Mayne Pharma Group Limited (ASX: MYX) - Financials
Current share price for MYX : $2.500 0.13 (4.94%)+
Mayne Pharma Group Limited (MYX) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is an ASX-listed specialty pharmaceutical company focused on commercializing branded women's health and dermatology pharmaceuticals.
MYX Per Share
| Year to Jun | Sales | Cashflow | Earnings | Dividends | Franking | Book Value | Average Annual P/E |
Relative P/E | Shareholder Return |
|---|---|---|---|---|---|---|---|---|---|
| 2026 | $3.61 | 13.1 ¢ | 49.6 ¢ | 0 ¢ | 0% | $4.81 | 7.47 | 50.8% | -44.2% |
| 2025 | $5.16 | 22.1 ¢ | -96.5 ¢ | 0 ¢ | 0% | $4.56 | 0 | 0% | 6.2% |
| 2024 | $4.89 | -19.2 ¢ | -167.2 ¢ | 0 ¢ | 0% | $5.59 | 0 | 0% | 7% |
MYX Capital Structure
| Total Debt | Interest | Long Term Debt | Percent Debt | Preferred Stock | Share Equity | Percent Equity |
|---|---|---|---|---|---|---|
| $43,197 | $39,525 | $1,552.00 | 0% | $0.00 | $390,941 | 100% |
Note: All dollars in thousands ('000) for the table above
MYX Historical Financials
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Revenue ($M) | 384.1 | 408.4 | 389.5 |
| Operating Margin (%) | 40.8 | 8.5 | -14.9 |
| Depreciation ($M) | -7.8 | -8.3 | -8.8 |
| Amortisation ($M) | -56 | -61 | -60 |
| Net Profit Before Abs ($M) | 52.7 | -76.4 | -133.2 |
| Net Profit After Abs ($M) | 24.5 | -93.8 | -174.2 |
| Income Tax Rate (%) | 12.8 | -8.1 | 11.3 |
| Net Profit Margin (%) | 13.7 | -18.7 | -34.2 |
| Employees ($T) | 0.5 | ||
| Long Term Debt ($M) | 1.6 | 2.7 | 35 |
| Shareholders Equity ($M) | 390.9 | 370.3 | 454.2 |
| Return on Capital (%) | 20 | -13 | -22 |
| Return on Equity (%) | 13.5 | -20.6 | -29.3 |
| Payout Ratio (%) |
MYX Cashflow
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Customer Receipts ($M) | 707 | 732 | 751 |
| Net Operating Cashflow ($M) | 13.9 | 17.5 | -15.3 |
| Net Investing Cashflow ($M) | 10 | -68 | 53 |
| Net Financing Cashflow ($M) | -1 | -1 | -24 |
MYX Market & Earnings
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Market Cap ($M) | 227 | 406 | 383 |
| Net Gearing (%) | -9.4 | -5 | -15.7 |
| Net Interest Cover (%) | 2.6 | -1 | -4.54 |
| Dividend Yield (%) | |||
| NTA Per Share ($) | -0.89 | -2.16 | -1.41 |
| EBITDA ($M) | 156.8 | 34.5 | -58.2 |
| EBIT ($M) | 93.1 | -34.7 | -126.7 |
| EBT Before Abs ($M) | 57.3 | -69.6 | -154.6 |
MYX Balance Sheet
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Cash ($M) | 80 | 59.8 | 110.1 |
| Debtors ($M) | 157.2 | 164.6 | 176.5 |
| Other Debtors ($M) | 17.4 | 16 | 16.8 |
| Prepayments ($M) | 24.5 | 16.4 | 19.2 |
| Inventories ($M) | 55.5 | 50.6 | 74.6 |
| Current Investments ($M) | 40.6 | 39.2 | |
| Other Current Assets ($M) | 4.85 | 4.82 | 24.27 |
| Total Current Assets ($M) | 339.5 | 352.8 | 460.6 |
| Receivables ($M) | 14.6 | 15.4 | 15.3 |
| Inventories ($M) | |||
| Property, Plant & Equipment ($M) | 115.9 | 115 | 100.6 |
| Accumulated Depreciation ($M) | -60.8 | -56.1 | -47.3 |
| Intangibles ex. Goodwill ($M) | 463.1 | 545.8 | 568.6 |
| Goodwill ($M) | |||
| Future Income Tax Benefit ($M) | 37.2 | 41.8 | 45.3 |
| Non-Current Investments ($M) | |||
| Other Non-Current Assets ($M) | |||
| Total Non-Current Assets ($M) | 570 | 661.8 | 682.6 |
| Total Assets ($M) | 909.4 | 1,014.6 | 1,143.2 |
| Accounts Payable ($M) | 194 | 174.3 | 244.5 |
| Provisions ($M) | 11 | 18.4 | 25.8 |
| Short Term Debt ($M) | 41.64 | 38.62 | 3.82 |
| Other Current Liabilities ($M) | 13.2 | 29.6 | 39.8 |
| Total Current Liabilities ($M) | 259.9 | 261 | 313.9 |
| Creditors ($M) | |||
| Long Term Debt ($M) | 1.55 | 2.65 | 35 |
| Provisions ($M) | 5.42 | 9.25 | 7.68 |
| Other Non-Current Liabilities ($M) | 251.6 | 371.4 | 332.4 |
| Total Non-Current Liabilities ($M) | 258.6 | 383.3 | 375.1 |
| Total Liabilities ($M) | 518.5 | 644.3 | 689 |
| Share Capital ($M) | 1,230 | 1,226 | 1,224 |
| Reserves ex. Share Premium ($M) | 177.7 | 185.3 | 174 |
| Share Premium Reserve ($M) | |||
| Retained Profits ($M) | -1,016.5 | -1,041 | -944 |
| Other Shareholders Equity ($M) | |||
| Convertible Equity ($M) | |||
| Outside Equity Interest ($M) | |||
| Total Shareholders Equity ($M) | 390.9 | 370.3 | 454.2 |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
